Creative Biolabs, a biotechnology pioneer, supplies recombinant antibody products for pharmaceutical breakthroughs. Their innovative antibody research and production pipelines, like high-throughput antibody production, glycosylation analysis of therapeutic glycoproteins, and tobacco-based expression system enable stable supply of miscellaneous antibody reagents required for biomedical research. In 2024, a group of scientists from Creative Biolabs will attend global biomedicine industry conferences to showcase their capabilities in antibody discovery and their latest antibody products.